Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in GlioblastomaKai Huang, Chunsheng Kang, Tao Jiang et al.|Advanced Science|2019Cited by 106
Platinum Prodrug Nanoparticles with COX‐2 Inhibition Amplify Pyroptosis for Enhanced Chemotherapy and Immune Activation of Pancreatic CancerBingzheng Yu, Yingjie Yu, Chaoyong Liu et al.|Advanced Materials|2023Cited by 102
Cancer Nanobombs Delivering Artoxplatin with a Polyigniter Bearing Hydrophobic Ferrocene Units Upregulate PD‐L1 Expression and Stimulate Stronger Anticancer ImmunityYongchao Gao, Chaoyong Liu, Hanchen Zhang et al.|Advanced Science|2023Cited by 29